The International Youth Development Foundation (IYDF), in partnership with Rao Study Circle, organized a compassionate outreach event for underprivileged children in the Dhurwa, Sector-01 community of Ranchi, Jharkhand. These children's families primarily rely on unstable sources of income, such as agriculture, construction, daily wage labor, and domestic work, which puts significant strain on their access to education and healthcare. To support these children, Hare Krishna Rao, the head of Rao Study Circle, took the initiative to bring together resources and support from various sectors of society.
The event was supported by a dedicated team of volunteers, including Prag Bhusan, Ranjani Kumari, Mukul Anand, Shivam Kumar, Shorya Pratik, Neelam Devi, and Naveen Sinha. They not only provided essential supplies for the children’s daily needs and education but also spent an afternoon filled with joy and warmth with the children.
Despite the unfavorable weather in Ranchi on the event day, the children's excitement and enthusiasm were undiminished. As soon as the volunteers arrived in the Dhurwa community, they were greeted with smiles and open arms. The aid distributed included rice, flour, lentils, sugar, vegetable oil, soy chunks, and stationery. While these items may seem simple, they are crucial for these children and their families.
Hare Krishna Rao expressed his hopes for the event, stating, “Through this activity, we aim not only to alleviate the immediate challenges these children face but also to make them feel the love and support of society, helping them develop a positive and hopeful outlook.”
During the distribution of aid, the volunteers engaged with the children through singing and music, creating a lively and joyful atmosphere. Prag Bhusan and Ranjani Kumari led the children in singing, their faces lighting up with happiness. Their enthusiastic participation brought immense joy to the volunteers. Prag Bhusan reflected, “Seeing the children's bright smiles as we sang is indescribably fulfilling. It reminds us that even in adversity, they hold onto hope for life.”
Notably, Smt. Neelam Chaudhary, State Minister of Women's Wing (Mahila Morcha) of Bharatiya Janata Party (BJP), was also invited to attend the event. Her presence added to the excitement of both the children and the volunteers. She assisted in distributing supplies and engaged in warm conversations with the children to learn about their lives and studies. She remarked, “Every child deserves a future filled with hope. Today's event has shown me their resilience and optimism. Our society needs to pay more attention to these vulnerable groups and help them overcome their challenges.”
Towards the end of the event, Mukul Anand and Neelam Devi had brief dialogues with the children, encouraging them to persevere in their studies and not give up on their dreams despite life's hardships. Shorya Pratik concluded, “What we've done today goes beyond material assistance; it's about showing these children that the future is still full of hope.”
This outreach event not only provided material assistance to the underprivileged children of the Dhurwa community but also offered them emotional support and encouragement. The volunteers from IYDF and Rao Study Circle conveyed warmth and compassion through their actions, helping these children maintain their smiles and steadfastly pursue their dreams in the face of adversity.
IYDF and Rao Study Circle Provide Support to Underprivileged Children in Dhurwa Community, Volunteers Unite to Build Hope<br>

More to Read
Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy BXCL501, a novel dexmedetomidine sublingual film, is under FDA review for potential at-home (outpatient) use for the acute treatment of agitation associated with schizophrenia or bipolar I or II
Genetic Testing Market Size to Surge to USD 62.61 Billion by 2035 – SNS Insider
U.S. Genetic Testing Market to Reach USD 16.92 Billion and Europe USD 18.78 Billion by 2035, Driven by NGS, Liquid Biopsy and Personalized Medicine Austin, Texas, Aug. 28, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Genetic Testing Market Size was valued at USD 21.67 billion in 2025 and is projected to reach USD 62.61 billion by 2035, expanding at a CAGR of 11.34% from 2026 to 2035. Reduction in sequencing cost, increasing use of genomics in clinical practice, and increased interest i
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders Teva Pharmaceuticals to serve as “stalking horse” bidder in a court-supervised 363 auction process BioXcel Therapeutics has secured a commitment for debtor-in-possession (DIP) financing to support ongoing operations NEW HAVEN, Conn., Aug. 28, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (“BioXcel Therapeutics” or the “Company”), a biopharmaceutic
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
ASHBURN, Va., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has entered into a securities purchase agreement with new and existing healthcare-focused institutional investors to raise up to approximately $50.0 million in gross proceeds, including initial upfront funding of approximately $30.8 million and up to an additional a
Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results
SHANGHAI, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Operational and Financial Highlights: Transaction volume 1 was RMB9.5 billion (US$1.4 billion), representing a decrease of 74.4% from the same period of 2025. Average borrowing amount per borrowing was RMB6,663 (US$982), representing a decrease
Form-8.3 APTITUDE SOFTWARE GROUP PLC - 27 08 2026 - (CGAML)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia
Form-8.3 GOOCH & HOUSEGO PLC - 27 08 2026 - (CGWL)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must
Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 08 2026 - (CGWL)
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!